Finally, it should be noted that an effect of ZNF804A on cytokine signaling could also help explain the development of metabolic syndrome, which occurs as a polymorphic trait in many patients treated with psychotrophic medications (and some untreated patients as well); metabolic syndrome is mediated by immune cytokines [133,162–167]. Here, ZNF804A is linked to metabolic syndrome.